1925 (1925) Fair Value & Analysis

Consumer Defensive · Market cap HK$498M

1 1925 1925 · HK

PriceHK$1.23

Fair ValueHK$1.78

Upside+44.7%

Quality52/100

Watch 1925 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$1.61 – HK$2.32

Fair value as of: Jul 2, 2026

From 17 valuation models · updated today

Share price −3.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.9510 – HK$1.30 · fair‑value band HK$1.61 – HK$2.32 · the HK$1.23 price screens below the HK$1.78 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1925 (1925) currently trades at HK$1.23, while our model-based Fair Value estimate is HK$1.78 — implying the stock looks roughly 44.7% undervalued today. We read business quality at 52/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1925 generated revenue of HK$882M at a net margin of 4.1%. Revenue declined 21.2% year over year. It earns a return on equity of 6.6%. The balance sheet holds a net cash position of HK$102M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$882M

Revenue growth (YoY) -21.2%

Net margin 4.1%

Return on equity 6.6%

Free cash flow −HK$1.2M FY2025

P/E ratio 12.3

More key figures

Operating margin 4.3%

EPS (TTM) HK$0.0600

EPS growth (YoY) -80.3%

Net cash HK$102M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1925 reported revenue of HK$882M in FY2025 versus HK$631M in FY2021, a compound +8.7%/yr. Reported net income was HK$35.9M in FY2025, compounding −7.5%/yr from FY2021.

Revenue +8.7%/yr

FY21 HK$631M

FY22 HK$719M

FY23 HK$807M

FY24 HK$1.0B

FY25 HK$882M

Net income −7.5%/yr

FY21 HK$49.0M

FY22 HK$52.6M

FY23 HK$60.6M

FY24 HK$119M

FY25 HK$35.9M

Is 1925 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
PG PG	2,590 MXN	1,415 MXN	-45%
The Procter & Gamble Company PGCO34	R$53.60	R$29.97	-44%
L'Oréal S.A LRLCF	$428.02	$273.79	-36%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.16	€55.96	-29%
Hindustan Unilever Limited HINDUNILVR	₹2,122	₹677.55	-68%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1925 (1925) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$1.78 versus a price of HK$1.23 — about +45% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1925?

Our model-based fair value for 1925 is HK$1.78 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.23.

What is the quality score of 1925?

1925 has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1925 (1925)?

1925 reported trailing-twelve-month revenue of about HK$882M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1925?

The net profit margin of 1925 is about 4.1%, meaning it keeps roughly 4.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.